Dysplastic Cells: What They Are, Cancer Risk & Screening Importance

Understanding Dysplasia

Dysplastic cells are abnormal cells with disordered growth, architecture, and cytology. They are pre‑cancerous—not cancer, but with increased malignant potential if untreated.

Key Features

Nuclear enlargement, hyperchromasia, irregular membranes
Increased mitotic figures (including abnormal forms)
Loss of normal polarity and stratification
Graded: mild (low‑grade), moderate, severe (high‑grade/CIS)

Common Sites & Screening

Management Principles

Low‑grade: Often surveillance; may regress.
High‑grade: Excision/ablation (LEEP, cone biopsy, polypectomy, EMR).
Follow‑up: Intensified screening intervals per guidelines.
Risk reduction: HPV vaccination, smoking cessation, UV protection.

Critical Message

Dysplasia ≠ cancer. Early detection through recommended screening allows curative intervention. Adhere to age‑ and risk‑appropriate screening schedules.

Hodgkin Lymphoma - Related Articles

Site	Screening Test	Precursor Lesion
Cervix	Pap smear, HPV test	CIN (Cervical Intraepithelial Neoplasia)
Breast	Mammography, biopsy	ADH, DCIS (ductal)
Colon	Colonoscopy	Adenomatous polyps (tubular, villous)
Skin	Dermoscopy, biopsy	Actinic keratosis, Bowen’s disease
Lung	Low‑dose CT (high risk)	Bronchial dysplasia
Oral cavity	Visual exam, biopsy	Leukoplakia, erythroplakia